Authors: SCHILLING T FIEBIG HH KERPELFRONIUS S WINTERHALTER B VARIOL P TRESCA P HEINRICH B HANAUSKE AR

Citation: T. Schilling et al., CLINICAL-PHASE-I AND PHARMACOKINETIC TRIAL OF VINORELBINE ADMINISTERED AS SINGLE INTRAVENOUS BOLUS EVERY 21 DAYS IN CANCER-PATIENTS, Investigational new drugs, 14(4), 1996, pp. 371-378

Authors: HERRMANN R MROSS K KLEEBERG U BECHER R EDLER L QUEISSER W LIATI P KERPELFRONIUS S

Citation: R. Herrmann et al., 4'-IODO-4'-DEOXYDOXORUBICIN (IDX) IN COLORECTAL-CANCER - A MULTICENTER PHASE-II STUDY, Onkologie, 18(1), 1995, pp. 28-30

Authors: EBERHARDT W NIEDERLE N WILKE H WEIDMANN B HENSS H ENGELHARDT R ZEIDLER D COLAJORI E KERPELFRONIUS S SEEBER S

Citation: W. Eberhardt et al., PHASE-II STUDY OF 4'-IODO-4'-DEOXYDOXORUBICIN IN PATIENTS WITH ADVANCED, MEASURABLE NONSMALL CELL LUNG-CANCER, Onkologie, 16(6), 1993, pp. 446-448

Authors: KRALOVANSZKY J PRAJDA N KERPELFRONIUS S BAGRIJ T KISS E PETERS GJ

Citation: J. Kralovanszky et al., BIOCHEMICAL CONSEQUENCES OF 5-FLUOROURACIL GASTROINTESTINAL TOXICITY IN RATS - EFFECT OF HIGH-DOSE URIDINE, Cancer chemotherapy and pharmacology, 32(3), 1993, pp. 243-248